Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentPML body

TOPBP1 HIRA

3.08e-03125142GO:0016605
PathwayPID_FANCONI_PATHWAY

TOPBP1 FAN1

4.81e-0447102M1
Pubmed

Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb.

BMP2K FXR1

2.29e-051814223211419
Pubmed

Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.

BMP2K SRGAP2B ARHGEF28 FAN1

4.02e-0492514428986522
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF142 ZNF562

3.76e-027188228
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

TOPBP1 BMP2K FXR1 HIRA BBX

5.75e-05856145M4500
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

TOPBP1 FXR1 HIRA BBX

8.57e-05466144M13522
CoexpressionZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN

TOPBP1 FXR1

1.22e-0431142M16104
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP

ZNF142 ARHGEF28 GSTCD

1.41e-04196143M7718
CoexpressionGSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN

FXR1 HIRA BBX

1.50e-04200143M7686
ComputationalGenes in the cancer module 331.

HIRA FAN1

9.86e-047572MODULE_331
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

FXR1 HIRA BBX

1.83e-041861433279_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A

BMP2K FXR1 GSTCD

1.92e-041891434271_DN
DrugPyrimethamine [58-14-0]; Up 200; 16uM; HL60; HG-U133A

BMP2K HIRA BBX

2.10e-041951431974_UP
DrugFluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A

BMP2K HIRA BBX

2.13e-041961436247_DN
DrugQuinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A

BMP2K HIRA GSTCD

2.13e-041961437317_DN
DrugICI 182,780; Down 200; 1uM; ssMCF7; HG-U133A

ZNF142 HIRA GSTCD

2.13e-04196143523_DN
DrugPilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A

BMP2K HIRA FAN1

2.16e-041971435341_DN
DrugBenserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A

BMP2K FXR1 HIRA

2.16e-041971435322_DN
DrugMeprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A

BMP2K HIRA GSTCD

2.16e-041971433544_DN
DrugPropranolol hydrochloride [318-98-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A

BMP2K ARHGEF28 FAN1

2.20e-041981433396_DN
Drug9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A

BMP2K FXR1 GSTCD

2.20e-041981437500_DN
DrugQuinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

BMP2K ZNF562 GSTCD

2.20e-041981436267_UP
DrugAtropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; HL60; HG-U133A

ADAMTS12 ZNF142 FXR1

2.23e-041991431768_UP
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A

BMP2K ZNF142 HIRA

2.26e-042001436334_DN
Drugtestosterone enanthate

BMP2K FXR1 BBX ZNF562

3.29e-04575144ctd:C004648
DiseaseC-X-C motif chemokine 10 measurement

BMP2K ARHGEF28

8.71e-04109122EFO_0008056
DiseaseIschemic stroke

FXR1 ZNHIT6

7.38e-03324122HP_0002140
Diseaseschizophrenia, intelligence, self reported educational attainment

FXR1 BBX

8.37e-03346122EFO_0004337, EFO_0004784, MONDO_0005090
Diseasesevere acute respiratory syndrome, COVID-19

ADAMTS12 ARHGEF28

1.37e-02447122EFO_0000694, MONDO_0100096

Protein segments in the cluster

PeptideGeneStartEntry
KTSKGPFQSQKKNLF

BBX

731

Q8WY36
FKFAKKDCPVSNINN

BMP2K

316

Q9NSY1
PEFKKCNQQACKKSA

ADAMTS12

1521

P58397
APACTKKFQEKYNKN

ARHGEF28

696

Q8N1W1
FPSAQQKKKAFSTCS

OR6C70

226

A6NIJ9
NQNKTVKKNTFFKCT

FXR1

116

P51114
PNKCFTSFKNNSKEK

FAM214A

561

Q32MH5
KENSTFFDKKKQQFC

ZNHIT6

331

Q9NWK9
FKKKQKNGSSAKPSC

HIRA

281

P54198
NTSKFNFPKSEQFKK

GSTCD

546

Q8NEC7
KNKKKASNSIISCFN

FAN1

21

Q9Y2M0
AKTCSTKDQQFKKDQ

SRGAP2B

76

P0DMP2
KTKNCGKSFTNFSQL

ZNF562

261

Q6V9R5
NKSNNTKIFSKAKYC

ZBED9

236

Q6R2W3
LQCPNCQKFFTSKSK

ZNF142

191

P52746
VKFLKSSDNSKCFFK

TOPBP1

11

Q92547